Antiretroviral therapy coverage in Dominican Republic

Dominican Republic: Antiretroviral therapy coverage was 66.0% in 2024. ◆ Volatile

Latest (2024)
66.0%
Change on year
up 6.5%
World rank
87th
of 143 countries
All-time high
66.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage in Dominican Republic, 2000–2024

02040602000201220242000: 0 % of people living with HIV2001: 0 % of people living with HIV2002: 0 % of people living with HIV2003: 0 % of people living with HIV2004: 1 % of people living with HIV2005: 3 % of people living with HIV2006: 6 % of people living with HIV2007: 10 % of people living with HIV2008: 13 % of people living with HIV2009: 16 % of people living with HIV2010: 20 % of people living with HIV2011: 23 % of people living with HIV2012: 26 % of people living with HIV2013: 28 % of people living with HIV2014: 31 % of people living with HIV2015: 34 % of people living with HIV2016: 36 % of people living with HIV2017: 39 % of people living with HIV2018: 42 % of people living with HIV2019: 45 % of people living with HIV2020: 48 % of people living with HIV2021: 54 % of people living with HIV2022: 61 % of people living with HIV2023: 62 % of people living with HIV2024: 66 % of people living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage in Dominican Republic is 66.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 6.5% on the previous year and up 112.9% over ten years.

Over the whole period, antiretroviral therapy coverage in Dominican Republic peaked at 66.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Dominican Republic 87th out of 143 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage in Dominican Republic, year by year

Annual values for Antiretroviral therapy coverage (% of people living with HIV) in Dominican Republic, 2000 to 2024.
Year % of people living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 3.0% +200.0%
2006 6.0% +100.0%
2007 10.0% +66.7%
2008 13.0% +30.0%
2009 16.0% +23.1%
2010 20.0% +25.0%
2011 23.0% +15.0%
2012 26.0% +13.0%
2013 28.0% +7.7%
2014 31.0% +10.7%
2015 34.0% +9.7%
2016 36.0% +5.9%
2017 39.0% +8.3%
2018 42.0% +7.7%
2019 45.0% +7.1%
2020 48.0% +6.7%
2021 54.0% +12.5%
2022 61.0% +13.0%
2023 62.0% +1.6%
2024 66.0% +6.5%

Dominican Republic compared with similar countries

  • Dominican Republic's 66.0% is above the median for upper middle income countries, which is 65.5%, 1.0× the median. (40 countries reporting)
  • Dominican Republic's 66.0% is below the median for Latin America & Caribbean, which is 67.5%, 98% of the median. (24 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage in Dominican Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +200.0% 1.0% 3.0%
2006 +100.0% 3.0% 6.0%
2007 +66.7% 6.0% 10.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.9% 0.0% 16.0% 10
2010s 32.4% 20.0% 45.0% 10
2020s 58.2% 48.0% 66.0% 5

Countries ranked near Dominican Republic

  1. 86 Panama 67.0% compare
  2. 87 Central African Republic 66.0% compare
  3. 87 Colombia 66.0% compare
  4. 87 Greece 66.0% compare
  5. 87 Iraq 66.0% compare
  6. 87 Niger 66.0% compare

See the full ranking of 166 places →

More health data for Dominican Republic

All data for Dominican Republic →

Frequently asked questions

What is antiretroviral therapy coverage in Dominican Republic?
Antiretroviral therapy coverage in Dominican Republic was 66.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage recorded in Dominican Republic?
The highest recorded value was 66.0% in 2024.
What is the lowest antiretroviral therapy coverage recorded in Dominican Republic?
The lowest recorded value was 0.0% in 2000.
How does Dominican Republic rank for antiretroviral therapy coverage?
Dominican Republic ranks 87th out of 143 countries with data for 2024.
Is antiretroviral therapy coverage rising or falling in Dominican Republic?
Over the last ten years it is up 112.9%. The long-run trend across the full record is volatile.
Where does this Dominican Republic data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage in Dominican Republic. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 15 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/dominican-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/dominican-republic/">Antiretroviral therapy coverage in Dominican Republic</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.